RG

Ravindersingh Gamdoorsingh Bamrah

Active Director Director DIN 07477977
DIN 07477977 First appointment Nov 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravindersingh Gamdoorsingh Bamrah

Data last updated:

Ravindersingh Gamdoorsingh Bamrah is a Director at Genex Remedies Private Limited (since 2016). The company operates in Business Services.

DIN 07477977
Primary Designation Director
Industry Business Services
First Appointment 09 Nov 2016
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genex Remedies Private Limited U74999MH2016PTC287556
Director09 Nov 20162016Active

Board colleagues of Ravindersingh Gamdoorsingh Bamrah

Directorship timeline

Open interactive timeline →
Genex Remedies Private Limited
Premium access

Shareholding and investment profile for Ravindersingh Gamdoorsingh Bamrah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindersingh Gamdoorsingh Bamrah

Ravindersingh Gamdoorsingh Bamrah currently holds 1 directorship: Genex Remedies Private Limited (Director, since 09 Nov 2016).

Ravindersingh Gamdoorsingh Bamrah was first appointed on 09 Nov 2016 as Director at Genex Remedies Private Limited.

The current boards of Ravindersingh Gamdoorsingh Bamrah's companies include Bhavdeep Singh Mahinderpal Singh Sahani (Genex Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available